Relypsa Plunges After Veltassa FDA Approval; Wedbush Says 'Misunderstanding' Creates Buying Opportunity
October 22, 2015 at 12:58 PM EDT
Relypsa Inc (NASDAQ: RLYP) confirmed that the FDA has approved patiromer Veltassa for the treatment of ...